Literature DB >> 12149249

Direct identification of tyrosine 474 as a regulatory phosphorylation site for the Akt protein kinase.

Nelly Marmy Conus1, Katherine M Hannan, Briony E Cristiano, Brian A Hemmings, Richard B Pearson.   

Abstract

Understanding the regulation of Akt has been of major interest for elucidating the control of normal cellular physiology as well as malignant transformation. The paradigm for activation of Akt involves phosphatidylinositol 3-kinase-dependent membrane localization followed by activating phosphorylation of Thr-308 and Ser-473. Many of the activating signals for Akt involve the stimulation of receptor and non-receptor tyrosine kinases, and the most potent activator known is the tyrosine phosphatase inhibitor pervanadate, highlighting a possible role for tyrosine phosphorylation in the regulation of the enzyme. In this study we show that activation of Akt by pervanadate or serum is associated with tyrosine phosphorylation of Akt. In addition, in SKOV3 ovarian carcinoma cells that exhibit high basal levels of Akt activity, Akt was tyrosine-phosphorylated in the basal state, and this phosphorylation was further enhanced by both pervanadate and insulin-like growth factor-1. We have used NH(2)-terminal sequencing and phosphate release analysis to directly identify Tyr-474 as the site of tyrosine phosphorylation. Substitution of Tyr-474 with phenylalanine abolished tyrosine phosphorylation of Akt and resulted in up to 55% inhibition of Akt activation, indicating phosphorylation at Tyr-474 is required for full activation of the kinase. Our data identifies a novel regulatory mechanism for this pleiotropic enzyme that may be applicable to the AGC family of protein kinases given the conserved nature of the COOH-terminal hydrophobic motif containing Tyr-474.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149249     DOI: 10.1074/jbc.M203387200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  PI3K-independent AKT activation in cancers: a treasure trove for novel therapeutics.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  J Cell Physiol       Date:  2012-09       Impact factor: 6.384

2.  Quantitative analysis of Akt phosphorylation and activity in response to EGF and insulin treatment.

Authors:  Neil Kumar; Raffi Afeyan; Sarah Sheppard; Brian Harms; Douglas A Lauffenburger
Journal:  Biochem Biophys Res Commun       Date:  2007-01-02       Impact factor: 3.575

Review 3.  Targeting the PI3-kinase/Akt/mTOR signaling pathway.

Authors:  Burhan Hassan; Argun Akcakanat; Ashley M Holder; Funda Meric-Bernstam
Journal:  Surg Oncol Clin N Am       Date:  2013-08-06       Impact factor: 3.495

4.  3-D structure and dynamics of protein kinase B-new mechanism for the allosteric regulation of an AGC kinase.

Authors:  Véronique Calleja; Michel Laguerre; Banafshé Larijani
Journal:  J Chem Biol       Date:  2009-02-20

5.  Androgen receptor levels are upregulated by Akt in prostate cancer.

Authors:  Susan Ha; Rachel Ruoff; Nicole Kahoud; Thomas F Franke; Susan K Logan
Journal:  Endocr Relat Cancer       Date:  2011-03-09       Impact factor: 5.678

6.  Akt Kinase Activation Mechanisms Revealed Using Protein Semisynthesis.

Authors:  Nam Chu; Antonieta L Salguero; Albert Z Liu; Zan Chen; Daniel R Dempsey; Scott B Ficarro; William M Alexander; Jarrod A Marto; Yana Li; L Mario Amzel; Sandra B Gabelli; Philip A Cole
Journal:  Cell       Date:  2018-08-02       Impact factor: 41.582

7.  Asymmetric dimethylarginine induces endothelial nitric-oxide synthase mitochondrial redistribution through the nitration-mediated activation of Akt1.

Authors:  Ruslan Rafikov; Olga Rafikova; Saurabh Aggarwal; Christine Gross; Xutong Sun; Julin Desai; David Fulton; Stephen M Black
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

8.  Regulation of mTORC1 signaling by Src kinase activity is Akt1-independent in RSV-transformed cells.

Authors:  Martina Vojtechová; Jolana Turecková; Dana Kucerová; Eva Sloncová; Jirí Vachtenheim; Zdena Tuhácková
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

9.  Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms.

Authors:  Alfredo Csibi; David Communi; Nathalie Müller; Serge P Bottari
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

10.  Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation.

Authors:  Kiran Mahajan; Domenico Coppola; Sridevi Challa; Bin Fang; Y Ann Chen; Weiwei Zhu; Alexis S Lopez; John Koomen; Robert W Engelman; Charlene Rivera; Rebecca S Muraoka-Cook; Jin Q Cheng; Ernst Schönbrunn; Said M Sebti; H Shelton Earp; Nupam P Mahajan
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.